The global Amlodipine Besylate market volume was nearly 12 thousand tonnes in 2023 and is anticipated to grow at a CAGR of 3.5% during the forecast period until 2034.
Amlodipine Besylate is a vital component in the pharmacological arsenal for managing hypertension, either as monotherapy or in combination with other drugs. Its efficacy lies in its ability to mitigate high blood pressure, thereby reducing the risk of critical cardiovascular events like strokes, heart attacks, and renal complications. As a member of the calcium channel blocker class, Amlodipine Besylate functions by inducing vasodilation, facilitating smoother blood flow through relaxed blood vessels. Additionally, it finds application in preventing specific forms of angina, enhancing exercise tolerance, and diminishing the frequency of angina.
The global Amlodipine Besylate market is driven by several key factors. Firstly, the escalating global prevalence of hypertension is fuelling demand for this medication, driven by factors such as aging populations and lifestyle-related health issues like obesity. Secondly, the expiration of patents has ushered in a wave of generic alternatives, intensifying competition, and making treatment more accessible. Thirdly, there's a notable focus on combination therapies, with Amlodipine Besylate being a key component for enhanced efficacy in blood pressure management, presenting avenues for innovative drug formulations. Lastly, the increasing awareness and awareness about hypertension, fostering early diagnosis and treatment initiation, thus potentially augmenting the demand for Amlodipine Besylate. These trends collectively shape the market dynamics, indicating a growing market with evolving strategies to address the burgeoning need for hypertension treatment. The global Amlodipine Besylate market is likely to reach approximately 18 thousand tonnes in 2034.
Geographically, North America stands as a significant consumer of Amlodipine Besylate and is poised to maintain this position in the coming years. This dominance is underpinned by several factors, including the region's high prevalence of hypertension, driven by lifestyle factors and an aging population. Additionally, North America's advanced healthcare infrastructure and widespread access to medical services ensure the extensive prescription and utilization of Amlodipine Besylate. Stringent pharmaceutical regulations uphold the quality and availability of medications, further reinforcing its market presence. Moreover, increasing public awareness campaigns regarding hypertension contribute to early diagnosis and treatment initiation, sustaining the demand for Amlodipine Besylate.
Based on end-use applications, the global Amlodipine Besylate market is segmented into High Blood Pressure, Heart Disease, and Others. Among these applications, High Blood Pressure is the major application.
Major players in the Global Amlodipine Besylate market are Aurobindo Pharma, Pfizer, Dr. Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma, Upsher-Smith Laboratories, InvaGen Pharmaceuticals, Mylan, Lupin Pharmaceuticals, Zydus Pharmaceuticals, Oxford Pharm, Wockhardt, Epic Pharma, CR Pharmaceutical, Alkem Laboratories, and Others.
Years considered for this report:
Historical Period: 2015- 2022
Base Year: 2023
Estimated Year: 2024
Forecast Period: 2025-2034
This report will be delivered on an online digital platform with one-year subscription and quarterly update.
Objective of the Study:
• To assess the demand-supply scenario of Amlodipine Besylate which covers production, demand and supply of Amlodipine Besylate market in the globe.
• To analyse and forecast the market size of Amlodipine Besylate
• To classify and forecast Global Amlodipine Besylate market based on end-use and regional distribution.
• To examine competitive developments such as expansions, mergers & acquisitions, etc., of Amlodipine Besylate market in the globe.
To extract data for Global Amlodipine Besylate market, primary research surveys were conducted with Amlodipine Besylate manufacturers, suppliers, distributors, wholesalers and traders. While interviewing, the respondents were also inquired about their competitors. Through this technique, ChemAnalyst was able to include manufacturers that could not be identified due to the limitations of secondary research. Moreover, ChemAnalyst analyzed various segments and projected a positive outlook for Global Amlodipine Besylate market over the coming years.
ChemAnalyst calculated Amlodipine Besylate demand across the globe by analyzing the volume of Amlodipine Besylate consumed by the End-Use Applications and the forecast is calculated based on the growth rate of end-use industries. ChemAnalyst sourced these values from industry experts and company representatives and externally validated them by analyzing the historical sales data of respective manufacturers to determine the overall market size. Various secondary sources such as company websites, association reports, annual reports, etc., were also studied by ChemAnalyst.
Key Target Audience:
• Amlodipine Besylate manufacturers and other stakeholders
• Organizations, forums and alliances related to Amlodipine Besylate distribution
• Government bodies such as regulating authorities and policy makers
• Market research organizations and consulting companies
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as Amlodipine Besylate manufacturers, customers and policy makers. The study would also help them to target the growing segments over the coming years, thereby aiding the stakeholders in taking investment decisions and facilitating their expansion.
Report Scope:
In this report, Global Amlodipine Besylate market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Attribute
Details
Market size Volume in 2023
12 thousand tonnes
Market size Volume in 2034
18 thousand tonnes
Growth Rate
CAGR of 3.5% from 2024 to 2034
Base year
2023
Estimated year
2024
Historical Data
2015 – 2022
Forecast period
2025 – 2034
Quantitative units
Demand in thousand tonnes and CAGR from 2024 to 2034
Report coverage
Industry Market Size, Capacity by Company, Capacity by Location, Operating Efficiency, Production by Company, Demand by Type, Demand by End-Use Application, Demand by Region, 9. Demand by Distribution Channel, Demand-Supply Gap, Company Share, Manufacturing Process.
Segments covered
By End-Use Application: (High Blood Pressure, Heart Disease, and Others)
By Sales Channel: (Direct Sale and Indirect Sale)
Regional scope
North America, Europe, Asia Pacific, Middle East and Africa, and South America.
I am satisfied with overall performance of ChemAnalyst. Weekly updates before the final report were especially helpful and reassuring. Additional requests on the interim and/or final reports were handled in a swift and professional manner
Mr.Shin Dosho
Member - Board of Directors
Osaka Gas Co. Ltd
Disruption Tracker
Disruption Tracker reflect the major shutdown on monthly basis which will help you in
tracking the inventory management and smooth functioning of business. Unforeseen shutdowns and disruptions
resulting in a loss of production capacity to impact the bottom line. The capacity tracker provides industries
with a global view of production and consumption capacity loss that reflects the corresponding conversion factors.
It also highlights the immediate impact on supply due to planned and unplanned outages as well as upcoming start-up
of new capacities. Additionally, it emphasizes how each shutdown—whether due to a maintenance turnaround or a case
of force majeure, affects the plant's operating rate for the given duration. Disruption tracker gives a clear insight
into the worldwide outages affecting the commodity of interest. With every shutdown, it also reflects the impact on
supply of the product in the market at a Global level.
What was the net market size of Amlodipine Besylate in terms of volume in 2023?
Ans:
The global market size of Amlodipine Besylate has reached approximately 12 thousand tonnes in 2023.
Q2.
Which region is a prominent consumer of Amlodipine Besylate?
Ans:
North America is a prominent consumer of Amlodipine Besylate globally.
Q3.
Do you offer single or multiuser license?
Ans:
Online Access 12 Months – Single User License (Up to 3 users can access the database) Online Access 12 Months – Enterprise License (Up to 10 Users can access the database)
Q4.
Will I get access to the analyst who authored this report?
Ans:
You will have 24/7 access to the analyst during the subscription period.
Our Solutions
Custom Research
We at ChemAnalyst provide tailor-made solutions to our clients based on their requirements which help them in building and expanding their business by developing customized strategy such as sales strategy, GTM Strategy, product portfolio and new product development. Our dedicated team helps clients in getting the best solution for their requirements. We at ChemAnalyst look forward to serving our clients for long term association.
Techno Economic Feasibility Report (TEFR)
ChemAnalyst provide TEFR reports which include market sizing, plant cost (ISBL and OSBL units), financial modelling, covering all the major financial calculations and ratios including production cost, IRR, major technology, licensing fee (if required), and others fixed and variable costs. TEFR reports will help the client to build greenfield project as well as brownfield expansion for a specific geography. Our Team of experts have delivered multiple TEFR reports which help clients in moving ahead of their business competition by grabbing the opportunity and expanding their business portfolio.
Price Benchmarking
Pricing benchmark report provides real-time data perpetuating current market scenarios, in a world that is changing at a rapid pace, having real-time prices is an imperative to make impactful insights and thereby informed decisions. The Price Benchmarking report provides pricing data for an individual market, or group of markets, which can be converted into localized insights and comparable listings. Benchmarking Reports help clients to make informed decisions by construing the data on several filters: region, country, category, grade and subsequently increasing their brand presence. Clients majorly require pricing benchmarks when they opt for a competitive pricing strategy.